Menu
Log in

HOME  /  JOIN  /  MAILING LIST  /  CONTACT US  /  WECHAT

Log in

GuidelinesGuidelines

Publications Publications

HUMAN GLYCOPROTEOMICS INITIATIVE


Leadership and Team members

Chair:


Morten Thaysen-Andersen, PhD

Macquarie University, Sydney, Australia



Co-Chairs:



Daniel Kolarich, PhD

Griffith University, Gold Coast, Australia




Nicolle H Packer, PhD

Macquarie University, Sydney, Australia




Early Career Researchers:


Rebeca Kawahara, PhD

Macquarie University, Sydney, Australia



Tiago Oliveira, PhD

IMBA, Austrian Academy of Sciences, Vienna, Austria


1st HGI Study (2017-2021)


Read more...


2nd HGI Study (2022-   )

Read more...


Post-study benchmarking of recent glycopeptide software against developers included in the 1st HGI study

To make best use of methodology and outcomes of the 1st HGI study and to bridge to the 2nd HGI study, which is well underway, the Human Glycoproteomics Initiative are here making the community aware of a post-study benchmarking opportunity for new and updated software against the performance of the nine developer teams that completed the 1st HGI study (Kawahara et al., Nat Methods, 2021). The accuracy and value of such a post-study benchmarking effort is critically dependent on the adherence to the published study guidelines. Notably, the resulting performance profiles should be viewed in the light that software included in the post-study phase may have benefitted from completing the study after the publication of the 1st HGI study outcomes. Developers interested in the benchmarking of new and updated versions of existing software for glycopeptide data analysis can contact A/Prof Morten Andersen or Dr Rebeca Kawahara to discuss further. The performance profiles of the post-study benchmarking will be made publicly available through this site to benefit the community.

The first software to be tested in this post-study benchmarking effort was MSFragger-Glyco (Polasky et al., Nat Methods, 2020), which missed the 1st HGI comparison due to the development of the software after the study evaluation period. The MSFragger-Glyco developer team headed by Prof Nesvizhskii and Dr Dan Polasky completed the post-study in April 2022 using a new release of MSFragger-Glyco version v3.5 in FragPipe 18.0 according to the study guidelines and submitted their lists of identified N- and O-glycopeptides using the common HGI reporting template to HGI-affiliated Dr Rebeca Kawahara who analysed the data in May 2022. Dr Kawahara established the relative performance profile of MSFragger-Glyco using the same scorecard system as used in the 1st HGI study. The performance profile of MSFragger-Glyco relative to the performance of the original nine developer software solutions suggests that MSFragger-Glyco is a promising high-performance tool not least for O-glycoproteomics where this search engine stood out from other tested software (see associated Figure).

The Human Glycoproteomics Initiative acknowledges Dr Rebeca Kawahara for performing the post-study benchmarking of MSFragger-Glyco and Prof Alexey Nesvizhskii and Dr Dan Polasky for completing the glycopeptide challenge and for agreeing to making the performance data of MSFragger-Glyco publicly available.        


Other Community Initiatives in the Glycosciences:

The Human Glycome Project

Announcements & upcoming events


2nd HGI Study now open and recruiting glycoproteomic software developer teams

Deadline to join is May 1, 2022

27th Annual Lorne Proteomics Symposium 2022

Saturday, Feb 5 - 4:00PM

Community Evaluation of Glycoproteomics Software - Morten Thaysen-Andersen

Link to recorded talk

 

Future HGI studies

Follow-up efforts seeking to compare the performance of the most recent glycoproteomics software upgrades and informatics solutions not included in the 1st HGI study are being drafted within the next study of the Human Glycoproteomics Initiative. Studies addressing key challenges relating to glycopeptide data acquisition are also planned. Community-wide calls for participation in these studies will be made soon.





The Human Proteome Organization is a 501(c)(3) tax exempt non-profit organization registered in the state of New Mexico.  |  © 2001-2022 HUPO. All rights reserved. 

Powered by Wild Apricot Membership Software